文献速递外周动脉疾病

既往搭桥失败后再次血运重建:开放手术与腔内治疗的全国性结局比较

National Utilization and Outcomes of Redo Lower Extremity Bypass versus Endovascular Intervention after a Previous Failed Bypass.
PubMed 文献 · Ann Vasc Surg · 2017-09-07

基于NSQIP血管靶向文件(2011-2014),在8,066例因严重肢体缺血行血运重建的患者中,1,606例为同侧股下段既往搭桥失败后的再次干预。大隐静脉搭桥的30天主要不良肢体事件(MALE)低于人工血管/拼接静脉搭桥和腔内干预,但腔内干预的MACE低于大隐静脉搭桥;MACE的独立预测因素为充血性心衰和透析依赖。

要点

  • 同侧搭桥失败后再次血运重建中,腔内干预占28.7%,大隐静脉搭桥占32.3%,替代材料搭桥占39.0%。
  • 大隐静脉搭桥的MALE最低(10.8%),腔内干预最高(15.8%),差异主要由腔内干预组30天截肢率更高驱动。
  • MACE在腔内干预组最低(3.9%),大隐静脉搭桥组最高(7%),但三组30天死亡率无差异。

核心结论

  • 在既往同侧搭桥失败后的严重肢体缺血患者中,大隐静脉搭桥的肢体相关结局优于腔内干预和替代材料搭桥。
  • 对于需要替代材料的患者,腔内干预是可接受的替代方案;MACE主要由患者合并症而非血运重建方式预测。

研究设计与样本

  • 回顾性队列研究,使用NSQIP血管靶向文件(2011-2014)数据。
  • 共纳入8,066例因严重肢体缺血行血运重建的患者,其中1,606例为同侧搭桥失败后再次干预。
  • 比较三组:腔内干预(461例,28.7%)、大隐静脉搭桥(518例,32.3%)、替代材料搭桥(627例,39.0%)。
  • 主要结局为30天MALE(未处理的通畅性丧失、再干预或截肢)和MACE(卒中、心肌梗死或死亡)。

主要发现

  • MALE发生率:腔内干预15.8%,大隐静脉搭桥10.8%,替代材料搭桥15.5%(P=0.03)。
  • 30天截肢率:腔内干预7.8%,大隐静脉搭桥3.7%,替代材料搭桥5.3%(P=0.02)。
  • MACE发生率:腔内干预3.9%,大隐静脉搭桥7%,替代材料搭桥5.6%(P=0.049)。
  • 30天死亡率三组无差异(P=0.53)。
  • MALE独立预测因素:转运状态(OR=1.7,P=0.01)、吸烟(OR=1.5,P=0.02)、膝下血运重建(OR=1.6,P=0.004)、大隐静脉 conduit(OR=0.5,P=0.002)。

临床怎么用

  • 对于既往同侧搭桥失败且需再次血运重建的CLI患者,优先考虑大隐静脉搭桥以降低MALE风险。
  • 若患者缺乏大隐静脉,腔内干预可作为替代材料搭桥的可接受替代方案。
  • 围手术期应重点优化充血性心衰和透析依赖等合并症,以降低MACE风险。

局限性

  • 回顾性研究设计,可能存在选择偏倚。
  • 仅评估30天结局,缺乏长期随访数据。
  • 数据来源于 NSQIP 数据库,可能无法完全反映真实世界实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Redo lower extremity bypass (LEB) and infrainguinal endovascular intervention (IEI) are options to treat critical limb ischemia after a failed prior LEB, but the utilization and outcomes of each are poorly described. The purpose of this study was to compare 30-day major adverse limb events (MALEs) and major adverse cardiovascular events (MACEs) after LEB and IEI in patients with a failed prior ipsilateral LEB and determine risk factors for each composite outcome. METHODS: Patients with prior failed ipsilateral LEB who underwent LEB or IEI involving the same arterial segment for critical limb ischemia were identified in the National Surgical Quality Improvement Program (NSQIP) Vascular Targeted File (2011-2014). LEB with single-segment saphenous vein was compared to LEB with alternative conduit (prosthetic/spliced vein/composite) and IEI. Primary outcomes were MALE (untreated loss of patency, reintervention, or amputation) and MACE (stroke, myocardial infarction, or death). Multivariate analysis was utilized to identify independent predictors of MALE and MACE. RESULTS: Among 8,066 revascularizations performed for critical limb ischemia (CLI), 1,606 (461 [28.7%] IEI, 518 [32.3%] LEB saphenous, and 627 [39.0%] LEB alternative) were performed after failed ipsilateral LEB involving the same arterial segment. LEB with saphenous had lower MALE than LEB with alternate conduit and IEI (15.8% IEI, 10.8% saphenous, and 15.5% alternative, P = 0.03). Higher MALE was driven by higher 30-day amputation in IEI (7.8% IEI, 3.7% saphenous, and 5.3% alternative, P = 0.02). Independent predictors of MALE include transfer status (odds ratio [OR] = 1.7, P = 0.01), tobacco use (OR = 1.5, P = 0.02), infrageniculate revascularization (OR = 1.6, P = 0.004), and saphenous conduit (OR = 0.5, P = 0.002). MACE was also different between groups (3.9% IEI, 7% saphenous, and 5.6% alternative, P = 0.049), with no difference in 30-day mortality (P = 0.53). Independent predictors of MACE included congestive heart failure (OR = 3.0, P = 0.01) and dialysis dependence (OR = 2.5, P = 0.02). CONCLUSIONS: In this large national sample representing routine vascular care of patients with CLI after failed ipsilateral LEB of the same arterial segment, IEI is common and represents 30% of revascularizations in this data set. Redo LEB with saphenous is associated with superior limb-related outcomes, but IEI offers an acceptable potential alternative to bypass in patients who would require alternative conduit. Finally, perioperative care is critical as we demonstrate that patient comorbidities, not the method of revascularization, predicted MACE.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mehaffey JH, Shannon A, Hawkins RB, et al. National Utilization and Outcomes of Redo Lower Extremity Bypass versus Endovascular Intervention after a Previous Failed Bypass. Ann Vasc Surg. 2017. PMID: 28890062. doi:10.1016/j.avsg.2017.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。